News
NRA-Amlodipine 5 mg, DIN 02476460. Issue: Health products - Product safety. What to do: Check your bottle of NRA-Amlodipine 5 mg ...
Here are six new drug shortages and discontinuations, according to drug supply databases from the FDA.
Shares of Alembic Pharmaceuticals climbed over 12% after the company secured USFDA approval for its generic Doxorubicin ...
Paulina man wanted following large St. James Parish drug, gun bust by: Christian Olivier Posted: Jun 7, 2025 / 01:16 PM CDT Updated: Jun 7, 2025 / 05:14 PM CDT ...
The Food and Drug Administration (FDA) has approved Widaplik ™ (telmisartan, amlodipine and indapamide), a single pill combination therapy, for the treatment of hypertension, including as ...
11d
Medindia on MSNFDA Approves First Triple Combo Pill for HypertensionWIDAPLIK™, a newly FDA-approved triple combo pill, promises better blood pressure control for adults, including those starting hypertension treatment for the first time.
Some people should be wary of some fruit because they contain compounds which can actually interfere with important ...
WIDAPLIK is a proprietary single pill combination of three medicines: telmisartan, amlodipine and indapamide and is available in three doses: a standard dose and two low doses. It is the first and ...
Several comparative studies have investigated the efficacy and tolerability of the two drugs. Fixed once-daily low doses of amlodipine 5mg and candesartan cilexetil 8mg were compared during 8–12 ...
However, many of the leading drugs face patent expiration in the next 5 years, including Pfizer's Norvasc (amlodipine), which expires in late 2007. In 2006, Norvasc generated sales of $4.9 billion.
8don MSN
Grapefruit contains a number of compounds that can interfere with important medication, including those taken by millions of ...
A new era of hypertension treatment is on the horizon for U.S. | The drug is the first triple-combo pill for the initial treatment of hypertension in the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results